When was Theragenics founded?

Theragenics was founded in 1981 and raised its 1st funding round 24 years after it was founded.

Where is Theragenics located?

Theragenics is headquartered in Buford, United States.

Who is the current CEO of Theragenics?

Francis Tarallo of Theragenics.

How many employees does Theragenics have?

As of Apr 30, 2026, the latest employee count at Theragenics is 210.

Is Theragenics a funded company?

Theragenics is a funded company, having raised a total of $9.44M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on May 2005.

When was the latest funding round of Theragenics?

Theragenics' latest funding was a $***** Conventional Debt round on Nov 11, 2021, with participation from 1 investor.

Where does Theragenics rank among its competitors?

Theragenics ranks 4th amongst 16 active competitors, of which 7 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was C4 Imaging, which secured $1.5M in Feb, 2024.

Who are the top competitors of Theragenics?

Theragenics' top competitors include Koya Medical, Sensus Healthcare and Xoft. Among them, C4 Imaging secured the most recent funding round in February, 2024.

Theragenics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Theragenics Corporation is a medical device company that focuses on the cancer treatment and surgical markets. It manufactures and markets brachytherapy seeding devices that are used in the minimally invasive treatment of localized prostate cancer and of early-stage breast cancer. Its surgical products Also manufactures and distributes surgical products especially wound closure devices, needles and other surgical products. Clients include equipment manufacturers, a network of distributors, and directly to healthcare providers and group purchasing organizations. Has acquired the U.S. and Canadian seed business of Eckert & Ziegler BEBIG.

Key Metrics

Founded Year

1981

Location

Buford, United States

Stage

Acquired

Total Funding

$9.44M in 3 rounds

Latest Funding Round

Conventional Debt, Nov 11, 2021, $*****

Investors

Wingspire Capital

Ranked

4^th among 16 active competitors

Employee Count

210 as on Apr 30, 2026

Investment & Acquisitions

NeedleTech & 1 more

Similar Companies

Koya Medical & 14 more

Exit Details

Acquired by Juniper Investment Company (Aug 05, 2013)

View Theragenics' full profile

Theragenics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Theragenics Corp CIN: 581528626 , United States, Active	May 29, 1995	-	374 (As on Dec 31, 2024)	-

Theragenics got acquired by Juniper Investment Company on Aug 05, 2013.

Click here to take a look at Theragenics's acquisition in detail

Theragenics has raised a total funding of $9.44M over 3 rounds. Its first funding round was on May 2005. Its latest funding round was a Conventional Debt round on Nov 11, 2021 for $*****. 1 investor participated in its latest round. Theragenics has 1 institutional investor.

Here is the list of recent funding rounds of Theragenics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 11, 2021	3237571	Conventional Debt	3260803	9523383	7989005	5038360
Aug 2006	9972054	Series A	3976636	6037497	1706153	4903939
May 2005	2653055	Series A	8935566	2003203	9235772	6828864

Access funding benchmarks and valuations. Sign up today!

View details of Theragenics's funding rounds and investors

Theragenics' employee count trend

Theragenics has 210 employees as of Apr 26. Here is Theragenics's employee count trend over the years:

Uncover Theragenics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Theragenics include Koya Medical, Sensus Healthcare and Xoft. Here is the list of Top 10 competitors of Theragenics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Koya Medical 2018, Oakland (United States), Series B	Provider of smart wearable compression technology for lymphedema and venous diseases	$37M	Orbimed, Arboretum Ventures & 10 others	65/100
2nd	Sensus Healthcare 2010, Boca Raton (United States), Public	Medical device company specializing in non-invasive skin cancer and keloid treatments	$12.2M	-	60/100
3rd	Xoft 1998, Sunnyvale (United States), Acquired	Electronic brachytherapy for multiple cancers	$117M	RiverVest Venture Partners, Maverick Ventures ... & 9 others	50/100
4th	Theragenics 1981, Buford (United States), Acquired	Manufacturer of surgical products and brachytherapy devices	$9.44M	Wingspire Capital	35/100
5th	C4 Imaging 2009, Bellaire (United States), Seed	Provider of Image-guided procedures for the treatment of prostate cancer	$7.35M	Stoneworth Financial, NIH & 1 others	38/100
6th	Concure Oncology 2014, Mercer Island (United States), Series A	Breast microseed based radiotherapy for women diagnosed with early-stage breast cancer	$14M	Cascadia Venture Forum, Cowles Company	37/100
7th	CivaTech Oncology 2006, Durham (United States), Series A	Provider of polymer-based devices for localized low dose radiation therapy or brachytherapy	$12.4M	Philips HealthWorks, National Cancer Institute ... & 3 others	34/100
8th	IsoRay 1998, Richland (United States), Public	Isotopes for malignant cancer treatment through Brachytherapy	-	Vencore Capital	32/100
9th	RadioGel 2006, Richland (United States), Series A	Developing innovative radionuclide therapy for solid tumors, currently in clinical trials	$725K	-	31/100
10th	Mission-Driven Tech™ 2022, New York City (United States), Seed	Provider of awareness products combating cervical cancer	$20K	Techstars, Ankh Impact Ventures	29/100